Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey